NeoGenomics is trading at $18.51, up 4.1%, with no confirmed catalyst.

  • Shares rose to $18.59 after hours, but the reason for the move remains unclear.
  • No clear company-specific announcement was identified; the latest surfaced official release was a September 1 conference notice.
  • Healthcare sentiment is weak: XLV was down 1.32% pre-market, which does not explain the rise. Shares closed at $17.78 on October 1 after several declining sessions.